The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 May 2020
Historique:
received: 21 04 2020
revised: 08 05 2020
accepted: 08 05 2020
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 22 5 2020
Statut: epublish

Résumé

The current Coronavirus disease 2019 or COVID-19 pandemic has infected over two million people and resulted in the death of over one hundred thousand people at the time of writing this review. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though multiple vaccines and treatments are under development so far, the disease is only slowing down under extreme social distancing measures that are difficult to maintain. SARS-COV-2 is an enveloped virus that is surrounded by a lipid bilayer. Lipids are fundamental cell components that play various biological roles ranging from being a structural building block to a signaling molecule as well as a central energy store. The role lipids play in viral infection involves the fusion of the viral membrane to the host cell, viral replication, and viral endocytosis and exocytosis. Since lipids play a crucial function in the viral life cycle, we asked whether drugs targeting lipid metabolism, such as statins, can be utilized against SARS-CoV-2 and other viruses. In this review, we discuss the role of lipid metabolism in viral infection as well as the possibility of targeting lipid metabolism to interfere with the viral life cycle.

Identifiants

pubmed: 32429572
pii: ijms21103544
doi: 10.3390/ijms21103544
pmc: PMC7278986
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Dasman Diabetes Institute
ID : RA 2016-025

Références

Prog Lipid Res. 2003 Nov;42(6):479-97
pubmed: 14559068
J Exp Med. 2015 Oct 19;212(11):1851-68
pubmed: 26392224
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Clin Transl Immunology. 2019 Aug 05;8(8):e1073
pubmed: 31406574
Viruses. 2010 May;2(5):1106-9
pubmed: 21994673
Pharmacol Ther. 2018 May;185:34-49
pubmed: 29127024
World J Hepatol. 2017 Dec 28;9(36):1305-1314
pubmed: 29359013
Int J Mol Sci. 2019 Nov 26;20(23):
pubmed: 31779252
PLoS Pathog. 2013;9(4):e1003297
pubmed: 23637597
Science. 2019 Oct 18;366(6463):
pubmed: 31624181
Clin Microbiol Rev. 2015 Apr;28(2):465-522
pubmed: 25810418
JAMA Cardiol. 2020 Mar 27;:
pubmed: 32219356
Neurology. 2015 Mar 3;84(9):872-9
pubmed: 25636714
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Nat Cell Biol. 2009 May;11(5):510-20
pubmed: 19404330
Crit Care Med. 2011 Nov;39(11):2440-6
pubmed: 21725239
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Vet Rec. 2020 Mar 28;186(12):388
pubmed: 32221001
Antiviral Res. 2020 Apr;176:104752
pubmed: 32101770
J Virol. 2000 May;74(10):4634-44
pubmed: 10775599
New Sci. 2020 May 2;246(3280):9
pubmed: 32372835
BMJ. 2011 Apr 06;342:d1642
pubmed: 21471172
N Engl J Med. 2020 Apr 2;382(14):1370-1371
pubmed: 32163697
Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):44-9
pubmed: 23789924
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
F1000Res. 2019 Sep 12;8:
pubmed: 31559009
Nat Rev Endocrinol. 2019 Dec;15(12):689-700
pubmed: 31554932
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21504873
PLoS Biol. 2008 Sep 16;6(9):e226
pubmed: 18798692
Pharmacol Res. 2020 Apr;154:104170
pubmed: 30776422
PLoS Pathog. 2010 Jan;6(1):e1000719
pubmed: 20062526
Immunology. 2018 May;154(1):69-75
pubmed: 29392731
Arch Intern Med. 2009 Oct 12;169(18):1658-67
pubmed: 19822822
Cell Biol Toxicol. 2017 Oct;33(5):429-455
pubmed: 28275881
J Neuroimmunol. 2019 May 15;330:31-34
pubmed: 30784773
Cell. 2010 May 28;141(5):799-811
pubmed: 20510927
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741
pubmed: 32228322
Nature. 2013 Mar 14;495(7440):251-4
pubmed: 23486063
J Virol. 2015 Oct;89(20):10359-70
pubmed: 26246569
Nat Rev Drug Discov. 2020 May;19(5):305-306
pubmed: 32273591
Trends Microbiol. 2011 Jul;19(7):368-75
pubmed: 21530270
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1782-91
pubmed: 25810252
Trends Pharmacol Sci. 2020 Jun;41(6):363-382
pubmed: 32291112
Biochem Pharmacol. 2007 Jul 15;74(2):281-9
pubmed: 17521618
Eur Respir Rev. 2019 Nov 6;28(154):
pubmed: 31694841
Cell. 2006 Feb 24;124(4):729-40
pubmed: 16497584
J Clin Med. 2020 Feb 20;9(2):
pubmed: 32093211
Cold Spring Harb Perspect Biol. 2011 Oct 01;3(10):a004820
pubmed: 21628428
JAMA Cardiol. 2020 Mar 27;:
pubmed: 32219363
Crit Rev Oncol Hematol. 2007 Aug;63(2):150-9
pubmed: 17560117
Matrix Biol. 2018 Aug;68-69:230-247
pubmed: 29343457
JAMA. 2020 Feb 24;:
pubmed: 32091533
J Lipid Res. 2018 Sep;59(9):1671-1684
pubmed: 29946055
JAMA. 2013 Oct 23;310(16):1692-700
pubmed: 24108510
Cell Metab. 2014 Apr 1;19(4):694-701
pubmed: 24703700
Arch Med Sci. 2020 Apr 14;16(3):485-489
pubmed: 32399093
J Membr Biol. 2011 May;241(1):1-10
pubmed: 21468650
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3157-62
pubmed: 20133606
Nat Commun. 2019 Jan 10;10(1):120
pubmed: 30631056
Biotechnol J. 2020 Jun;15(6):e2000147
pubmed: 32304139
Nat Rev Immunol. 2020 Jun;20(6):347-348
pubmed: 32346094
BMJ. 2020 Apr 27;369:m1679
pubmed: 32340998
Biochem Soc Trans. 2002 Nov;30(Pt 6):1064-70
pubmed: 12440973
Sci Rep. 2017 Aug 22;7(1):9110
pubmed: 28831119
Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14889-94
pubmed: 15465916
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7158-E7165
pubmed: 29987044
Annu Rev Biochem. 1983;52:537-79
pubmed: 6137188
Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84
pubmed: 24841269
Pharmacol Ther. 2009 Oct;124(1):96-112
pubmed: 19576246
Biochim Biophys Acta. 2000 May 31;1485(2-3):63-99
pubmed: 10832090
PLoS Pathog. 2016 Oct 27;12(10):e1005912
pubmed: 27788266
Antiviral Res. 2013 Oct;100(1):215-9
pubmed: 23981392
Nat Rev Mol Cell Biol. 2018 Mar;19(3):175-191
pubmed: 29165427
JAMA Neurol. 2019 Oct 7;:
pubmed: 31589278
J Virol. 2018 Jan 30;92(4):
pubmed: 29167338
Nat Commun. 2015 Nov 12;6:8873
pubmed: 26561297
Pharmacol Res. 2016 Nov;113(Pt A):521-532
pubmed: 27663260
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Virol J. 2015 Dec 22;12:218
pubmed: 26690369
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Viruses. 2010 Apr;2(4):1011-49
pubmed: 21994669
Curr Pharm Des. 2006;12(35):4625-35
pubmed: 17168766
Mult Scler Relat Disord. 2020 Apr;39:102073
pubmed: 32334820
BMJ. 2020 Feb 28;368:bmj.m799
pubmed: 32111645
Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1951-6
pubmed: 24449882
BMJ. 2020 May 4;369:m1790
pubmed: 32366511
Science. 2020 Apr 3;368(6486):14-16
pubmed: 32241928

Auteurs

Mohamed Abu-Farha (M)

Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, 15462 Dasman, Kuwait.

Thangavel Alphonse Thanaraj (TA)

Department of Genetic and Bioinformatics, Dasman Diabetes Institute, 15462 Dasman, Kuwait.

Mohammad G Qaddoumi (MG)

Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, 15462 Dasman, Kuwait.
Pharmacology and Therapeutics Department, Faculty of Pharmacy, Kuwait University, 13110 Kuwait City, Kuwait.

Anwar Hashem (A)

Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 11633, Saudi Arabia.
Vaccines and Immunotherapy Unit, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah 80205, Saudi Arabia.

Jehad Abubaker (J)

Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, 15462 Dasman, Kuwait.

Fahd Al-Mulla (F)

Department of Genetic and Bioinformatics, Dasman Diabetes Institute, 15462 Dasman, Kuwait.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH